We are live on ! Find out more
CLVS

Clovis Oncology, Inc.
CLVS

Delisted

CLVS was delisted on the 20th of December, 2022.

Back to rankings

229 hedge funds and large institutions have $2.8B invested in Clovis Oncology, Inc. in 2017 Q1 according to their latest regulatory filings, with 86 funds opening new positions, 77 increasing their positions, 55 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

406% more first-time investments, than exits

New positions opened: 86 | Existing positions closed: 17

66% more capital invested

Capital invested by funds: $1.68B → $2.8B (+$1.12B)

40% more repeat investments, than reductions

Existing positions increased: 77 | Existing positions reduced: 55

37% more funds holding

Funds holding: 167 → 229 (+62)

36% more call options, than puts

Call options by funds: $100M | Put options by funds: $73.6M

0% more funds holding in top 10

Funds holding in top 10: 8 → 8 (0)

Holders
229
Holders Change
+62
Holders Change %
+37.13%
% of All Funds
5.7%
Holding in Top 10
8
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.2%
New
86
Increased
77
Reduced
55
Closed
17
Calls
$100M
Puts
$73.6M
Net Calls
+$26.5M
Net Calls Change
-$240K

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$185M
2
Fidelity Investments
Fidelity Investments
Massachusetts
+$80.7M
3
Wellington Management Group
Wellington Management Group
Massachusetts
+$80.2M
4
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$56.1M
5
Balyasny Asset Management
Balyasny Asset Management
Illinois
+$49.5M

Top Sellers

Rank Fund Capital Flow
1
CCM
Consonance Capital Management
New York
-$84.9M
2
PC
PointState Capital
New York
-$69.7M
3
NMC
NEA Management Company
Maryland
-$50.6M
4
SC
Samlyn Capital
New York
-$40.1M
5
RG
Redmile Group
California
-$39.4M
Name Holding Trade Value Shares
Change 		Change in
Stake
MCM
101
Moore Capital Management
New York
$2.55M +$2.43M +40,000 New
Allianz Asset Management
102
Allianz Asset Management
Germany
$2.33M +$2.22M +36,538 New
JG
103
Jefferies Group
New York
$2.23M +$2M +32,900 +1,567%
Wolverine Trading
104
Wolverine Trading
Illinois
$2.14M +$2.07M +34,111 New
DekaBank Deutsche Girozentrale
105
DekaBank Deutsche Girozentrale
Germany
$2.06M +$492K +8,100 +33%
ECM
106
Endurant Capital Management
California
$2.03M +$818K +13,450 +73%
TRSOTSOK
107
Teachers Retirement System of the State of Kentucky
Kentucky
$2M +$1.91M +31,420 New
PVI
108
Pura Vida Investments
New York
$1.99M +$1.9M +31,250 New
OPPM
109
Opus Point Partners Management
New York
$1.91M – – –
Russell Investments Group
110
Russell Investments Group
United Kingdom
$1.89M +$1.8M +29,692 New
CG
111
Cutler Group
California
$1.88M -$2.43M -40,040 -58%
ProShare Advisors
112
ProShare Advisors
Maryland
$1.79M -$155K -2,552 -8%
NIP
113
Nicholas Investment Partners
California
$1.77M +$1.69M +27,864 New
California Public Employees Retirement System
114
California Public Employees Retirement System
California
$1.76M +$164K +2,700 +11%
CIP
115
Chartwell Investment Partners
Pennsylvania
$1.73M +$1.65M +27,100 New
ClearBridge Investments
116
ClearBridge Investments
New York
$1.72M -$1.52M -25,000 -48%
TAM
117
Tocqueville Asset Management
New York
$1.65M +$743K +12,225 +89%
Manulife (Manufacturers Life Insurance)
118
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$1.64M +$228K +3,752 +17%
JGC
119
J. Goldman & Co
New York
$1.64M +$1.56M +25,700 New
MLICM
120
Metropolitan Life Insurance Company (MetLife)
New York
$1.62M +$114K +1,883 +8%
NI
121
Numeric Investors
Massachusetts
$1.58M +$207K +3,400 +16%
Federated Hermes
122
Federated Hermes
Pennsylvania
$1.47M +$525K +8,642 +60%
CC
123
Casdin Capital
New York
$1.46M +$1.4M +23,000 New
AIG
124
American International Group
New York
$1.42M +$241K +3,958 +22%
FWM
125
Frontier Wealth Management
Missouri
$1.41M -$53.2K -875 -4%
3 4
5
6 7

CLVS Hedge Fund Activity: Q1 2017 in Review

229 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in Clovis Oncology, Inc. (CLVS) for Q1 2017, worth a combined $2.8B — up 66% from $1.68B a quarter earlier.

Buyers outnumbered sellers: 86 funds opened new CLVS positions and 17 closed out — a net gain of 69 holders — while 77 added to existing stakes and 55 trimmed.

The largest buyer was BlackRock, adding an estimated $185M. The largest seller was Consonance Capital Management, cutting an estimated $84.9M.

  • 229 institutional investors held Clovis Oncology, Inc. (CLVS) as of Q1 2017, up from 167 in Q4 2016.
  • Funds reported $2.8B of Clovis Oncology, Inc. stock for Q1 2017, up 66% quarter-over-quarter.
  • 86 funds opened new Clovis Oncology, Inc. positions in Q1 2017 and 17 closed out, a net change of +69 holders.
  • The largest Clovis Oncology, Inc. buyer in Q1 2017 was BlackRock, an estimated $185M added.
  • The largest Clovis Oncology, Inc. seller in Q1 2017 was Consonance Capital Management, an estimated $84.9M sold.

Based on aggregated 13F filings for Q1 2017.